Markus R. Probst

1.8k total citations
20 papers, 1.6k citations indexed

About

Markus R. Probst is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Molecular Biology. According to data from OpenAlex, Markus R. Probst has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Health, Toxicology and Mutagenesis, 9 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Markus R. Probst's work include Toxic Organic Pollutants Impact (9 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Carcinogens and Genotoxicity Assessment (8 papers). Markus R. Probst is often cited by papers focused on Toxic Organic Pollutants Impact (9 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Carcinogens and Genotoxicity Assessment (8 papers). Markus R. Probst collaborates with scholars based in United States, Switzerland and Germany. Markus R. Probst's co-authors include Oliver Hankinson, Suzanne Reisz‐Porszasz, Barbara D. Abbott, Urs Meyer, Paul Jenö, Allan B. Okey, Gary H. Perdew, Marc Tessier‐Lavigne, Chen‐Ming Fan and Joseph Torchia and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Markus R. Probst

20 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus R. Probst United States 17 652 637 524 234 172 20 1.6k
Herminio Reyes United States 5 615 0.9× 623 1.0× 675 1.3× 187 0.8× 249 1.4× 7 1.5k
Jacqueline McGuire Sweden 16 507 0.8× 891 1.4× 848 1.6× 251 1.1× 247 1.4× 20 1.8k
J M Fisher United States 9 590 0.9× 558 0.9× 414 0.8× 98 0.4× 143 0.8× 11 1.4k
Burra V. Madhukar United States 26 616 0.9× 851 1.3× 414 0.8× 148 0.6× 222 1.3× 61 1.8k
Fred Sander United States 9 374 0.6× 426 0.7× 445 0.8× 170 0.7× 154 0.9× 11 1.1k
Ellen C. Henry United States 21 677 1.0× 387 0.6× 391 0.7× 104 0.4× 93 0.5× 31 1.3k
Suzanne Reisz‐Porszasz United States 14 790 1.2× 1.2k 1.9× 680 1.3× 470 2.0× 319 1.9× 17 2.4k
Togo Ikuta Japan 20 403 0.6× 913 1.4× 352 0.7× 105 0.4× 250 1.5× 31 1.7k
Grant Mason United Kingdom 25 367 0.6× 1.0k 1.6× 308 0.6× 124 0.5× 185 1.1× 38 1.6k
Mikael Gillner Sweden 15 348 0.5× 354 0.6× 211 0.4× 73 0.3× 249 1.4× 23 1.1k

Countries citing papers authored by Markus R. Probst

Since Specialization
Citations

This map shows the geographic impact of Markus R. Probst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus R. Probst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus R. Probst more than expected).

Fields of papers citing papers by Markus R. Probst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus R. Probst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus R. Probst. The network helps show where Markus R. Probst may publish in the future.

Co-authorship network of co-authors of Markus R. Probst

This figure shows the co-authorship network connecting the top 25 collaborators of Markus R. Probst. A scholar is included among the top collaborators of Markus R. Probst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus R. Probst. Markus R. Probst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welford, Richard W.D., Andreas Mühlemann, Peter Groenen, et al.. (2018). Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. Human Molecular Genetics. 27(19). 3392–3403. 31 indexed citations
2.
Welford, Richard W.D., Andreas Mühlemann, David A. Priestman, et al.. (2017). Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence. Molecular Genetics and Metabolism. 120(1-2). S139–S140. 7 indexed citations
3.
Beischlag, Timothy V., Song Wang, David W. Rose, et al.. (2002). Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex. Molecular and Cellular Biology. 22(12). 4319–4333. 176 indexed citations
4.
5.
Abbott, Barbara D., Markus R. Probst, Gary H. Perdew, & Angela R. Buckalew. (1998). AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGFα, TGFβ1, TGFβ2, and TGFβ3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology. 58(2). 30–43. 42 indexed citations
6.
Probst, Markus R., Chen‐Ming Fan, Marc Tessier‐Lavigne, & Oliver Hankinson. (1997). Two Murine Homologs of the Drosophila Single-minded Protein That Interact with the Mouse Aryl Hydrocarbon Receptor Nuclear Translocator Protein. Journal of Biological Chemistry. 272(7). 4451–4457. 79 indexed citations
7.
Clark, George C., et al.. (1997). Effects of TCDD on Ah receptor, ARNT, EGF, and TGF-α expression in embryonic mouse urinary tract. Teratology. 55(5). 326–337. 39 indexed citations
8.
Clark, George C., et al.. (1997). Effects of TCDD on Ah receptor, ARNT, EGF, and TGF‐α expression in embryonic mouse urinary tract. Teratology. 55(5). 326–337. 2 indexed citations
9.
Watson, Andrea, et al.. (1996). Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line.. Molecular Pharmacology. 50(6). 1454–1462. 40 indexed citations
10.
Probst, Markus R., et al.. (1995). Identification of Functional Domains of the Aryl Hydrocarbon Receptor. Journal of Biological Chemistry. 270(49). 29270–29278. 273 indexed citations
11.
12.
Abbott, Barbara D., Markus R. Probst, & Gary H. Perdew. (1994). Immunohistochemical double‐staining for Ah receptor and ARNT in human embryonic palatal shelves. Teratology. 50(5). 361–366. 29 indexed citations
13.
Reisz‐Porszasz, Suzanne, et al.. (1994). Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT).. Molecular and Cellular Biology. 14(9). 6075–6086. 214 indexed citations
14.
Probst, Markus R., Marc A. Beer, David G. Beer, et al.. (1994). Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase.. Journal of Biological Chemistry. 269(34). 21650–21656. 71 indexed citations
15.
Reisz‐Porszasz, Suzanne, et al.. (1994). Identification of Functional Domains of the Aryl Hydrocarbon Receptor Nuclear Translocator Protein (ARNT). Molecular and Cellular Biology. 14(9). 6075–6086. 78 indexed citations
16.
Probst, Markus R., et al.. (1993). Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.. Molecular Pharmacology. 44(3). 511–518. 173 indexed citations
17.
Probst, Markus R., et al.. (1993). 32P-postlabelling studies on the DNA adducts of the food mutagens/carcinogens IQ and PhIP--adduct formation in a chemical system, and by rat and human metabolism.. PubMed. 173–9. 8 indexed citations
18.
Probst, Markus R., et al.. (1992). The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis. 13(10). 1713–1717. 45 indexed citations
19.
Graf, Tyler N., Franck Broly, Francine Hoffmann, et al.. (1992). Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers. European Journal of Clinical Pharmacology. 43(4). 399–403. 51 indexed citations
20.
Probst, Markus R., Paul Jenö, & Urs Meyer. (1991). Purification and characterization of a human liver arylacetamide deacetylase. Biochemical and Biophysical Research Communications. 177(1). 453–459. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herminio Reyes Breakdown of academic impact, for papers by Jacqueline McGuire Breakdown of academic impact, for papers by J M Fisher Breakdown of academic impact, for papers by Burra V. Madhukar Breakdown of academic impact, for papers by Fred Sander Breakdown of academic impact, for papers by Ellen C. Henry Breakdown of academic impact, for papers by Suzanne Reisz‐Porszasz Breakdown of academic impact, for papers by Togo Ikuta Breakdown of academic impact, for papers by Grant Mason Breakdown of academic impact, for papers by Mikael Gillner
Rankless by CCL
2026